White Paper
PEPTIDES & OLIGONUCLEOTIDES
From a unique state-of-the-art platform for development and scale-up of Peptides and Oligonucleotides in Frankfurt (Germany), CEPiA offers customized services (manufacturing and analytical) and can provide the full scope of development activities from clinical phase up to submission and launch, including regulatory support, as well as commercial supplies.
